{
    "eid": "2-s2.0-84905302745",
    "title": "Metabolically Healthy Obesity\u2014Does it Exist?",
    "cover-date": "2014-10-01",
    "subject-areas": [
        {
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705"
        }
    ],
    "keywords": [
        "Adipose tissue inflammation",
        "Insulin resistance",
        "Metabolically healthy obese"
    ],
    "authors": [
        "Patchaya Boonchaya-Anant"
    ],
    "citedby-count": 61,
    "ref-count": 81,
    "ref-list": [
        "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013",
        "Medical consequences of obesity",
        "Annual medical spending attributable to obesity: Payer-and service-specific estimates",
        "Clinical relevance of adipokines",
        "Adiponectin: Mechanistic insights and clinical implications",
        "Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes",
        "The hormone resistin links obesity to diabetes",
        "Inflammation and insulin resistance",
        "Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes",
        "ISRN Oncol",
        "Obesity induces a phenotypic switch in adipose tissue macrophage polarization",
        "Adipocyte death, adipose tissue remodeling, and obesity complications",
        "Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity",
        "Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity",
        "Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity",
        "Mechanisms of inflammatory responses in obese adipose tissue",
        "Obesity is associated with macrophage accumulation in adipose tissue",
        "Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance",
        "Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects",
        "A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects",
        "The endocrine profile of subcutaneous and visceral adipose tissue of obese patients",
        "Subcutaneous adipose tissue macrophage infiltration is associated with hepatic and visceral fat deposition, hyperinsulinemia, and stimulation of NF-\u03baB stress pathway",
        "The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)",
        "The metabolically healthy but obese phenotype in African Americans",
        "Dysmetabolic signals in \"metabolically healthy\" obesity",
        "Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: Low inflammation and LDL oxidation in MHO women",
        "Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease",
        "Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis",
        "Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals",
        "Incident cardiovascular disease events in metabolically benign obese individuals",
        "Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: A cohort study",
        "Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality",
        "All-cause mortality risk of metabolically healthy obese individuals in NHANES III",
        "Prevalence, Metabolic features, and prognosis of metabolically healthy obese italian individuals: The cremona study",
        "Myocardial infarction and ischemic heart disease in overweight and obesity with and without metabolic Syndrome",
        "Are metabolically normal but obese individuals at lower risk for all-cause mortality?",
        "Beyond BMI: The \"metabolically healthy obese\" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality - A systematic review",
        "Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis",
        "Metabolically healthy obesity and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies",
        "Metabolically healthy obesity and risk of mortality: Does the definition of metabolic health matter?",
        "Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals",
        "What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?",
        "The metabolically healthy but obese individual presents a favorable inflammation profile",
        "Does inflammation determine metabolic health status in obese and nonobese adults?",
        "Insulin-sensitive obesity",
        "Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation",
        "Identification and characterization of metabolically benign obesity in humans",
        "Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis",
        "Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: Meta-regression analysis of prospective studies",
        "The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life",
        "Infant growth and later body composition: Evidence from the 4-component model",
        "Preadipocyte factor-1 is associated with metabolic profile in severe obesity",
        "Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity",
        "Inverse regulation of inflammation and mitochondrial function in adipose tissue defines extreme insulin sensitivity in morbidly obese patients",
        "Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity",
        "Macrophage activation and polarization",
        "T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance",
        "Normalization of obesity-associated insulin resistance through immunotherapy",
        "Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters",
        "Inflammation correlates with markers of T-cell subsets including regulatory T cells in adipose tissue from obese patients",
        "The AMPK signalling pathway coordinates cell growth, autophagy and metabolism",
        "Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin",
        "Adenosine 5\u2032-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype",
        "Macrophage \u03b11 AMP-activated protein kinase (\u03b11AMPK) antagonizes fatty acid-induced inflammation through SIRT1",
        "Ablation of AMP-activated protein kinase \u03b1 2 activity exacerbates insulin resistance induced by high-fat feeding of mice",
        "Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans",
        "Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue",
        "Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle.",
        "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase",
        "Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes",
        "Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: A new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus",
        "Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects",
        "Characterising metabolically healthy obesity in weight-discordant monozygotic twins",
        "Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population",
        "Metabolically healthy but obese, a matter of time? Findings from the prospective pizarra study",
        "Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle Factors",
        "Effects of a lifestyle intervention in metabolically benign and malign obesity",
        "Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus",
        "Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss"
    ],
    "affiliation": [
        {
            "affiliation-city": "Boston",
            "affilname": "Boston Medical Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Atkins Foundation",
        "Eli Lilly and Company",
        "Johnson and Johnson",
        "Orexigen Therapeutics"
    ]
}